Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

IMURAN 50 MG TABLET

azathioprine
$8.8907per EA

Strength

50 mg/1

Manufacturer

Sebela Pharmaceuticals Inc.

NDC

54766059010

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

4/4/2025

Active Ingredients

AZATHIOPRINE

Approval Type

New Drug (NDA)

FDA Application

NDA016324

On Market Since

12/1/2017

Pharmacological Classes

Nucleic Acid Synthesis Inhibitors
Nucleosides
Purine Antimetabolite
Purines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+4.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

EFUDEX 5% CREAM
Brand
00187320447•Bausch Health US LLC
$1.4420
per GM
TOLAK 4% CREAM
Brand
28105042140•HILL DERMACEUTICALS, INC.
$6.4181
per GM
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA
VEMLIDY 25 MG TABLET
Brand
61958230101•Gilead Sciences, Inc.
$51.9338
per EA
TRUVADA 200 MG-300 MG TABLET
Brand
61958070101•Gilead Sciences, Inc.
$59.7125
per EA
DESCOVY 120-15 MG TABLET
Brand
61958200501•Gilead Sciences, Inc.
$71.3937
per EA
DESCOVY 200-25 MG TABLET
Brand
61958200201•Gilead Sciences, Inc.
$71.4275
per EA
DESCOVY 200-25 MG TABLET
Brand
61958200202•Gilead Sciences, Inc.
$71.4275
per EA
DELSTRIGO 100-300-300 MG TAB
Brand
00006500701•Merck Sharp & Dohme LLC
$92.9143
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy